Connect with us

Life Sciences

Sonrai Analytics Novel Platform Empowers Pharma / Biotech to Transform Their Own Data Into a Multi-Billion-Dollar Competitive Edge

Global HealthTech venture firm Eckuity has announced that it has invested in Sonrai Analytics, a commercial stage data management and bioinformatics company….

Published

on

This article was originally published by AITHORITY
Sonrai Analytics Novel Platform Empowers Pharma / Biotech to Transform Their Own Data Into a Multi-Billion-Dollar Competitive Edge

Global HealthTech venture firm Eckuity has announced that it has invested in Sonrai Analytics, a commercial stage data management and bioinformatics company.

Staying ahead of the competition in pharma / biotech is about one thing, how you leverage your own data.

Pharma / biotech companies are sitting on billions of dollars of unrealized value buried deep in the petabyte piles of disorganized data they already own.

Sonrai’s platform empowers researchers to quickly integrate, process, and visualize complex, disparate and siloed datasets, shortening timelines and uncovering valuable insights. Importantly the platform ensures that data manipulations remain validated and regulatory compliant.

Recommended AI: Top 10 Countries and Cities by Number of CCTV Cameras

“We have rapidly enhanced our product and services by understanding our customer’s challenges and meeting their expectations. This additional capital further strengthens our commercial aspirations and allows us to diversify our market segments,” said Dr Darragh McArt, Founder and Chief Executive Officer of Sonrai Analytics. “We are delighted to have Eckuity join our team as we accelerate opportunities in the US and to provide advice and support as we progress the business.”

“Research companies and organizations are already sitting on a treasure trove of data, if only they could access it in a way that is easy to view and simple to integrate,” said Mark Goldstone, Partner at Eckuity. “Sonrai incorporates data visualization and predictive analytics into workflows to accelerate organizational processes, improve performance and unlock corporate value. We are very excited about the impact that Sonrai will have on the market.”

Recommended AI: How is Artificial Intelligence (AI) Changing the Future of Architecture?

[To share your insights with us, please write to sghosh@martechseries.com]

The post Sonrai Analytics Novel Platform Empowers Pharma / Biotech to Transform Their Own Data Into a Multi-Billion-Dollar Competitive Edge appeared first on AiThority.

bioinformatics

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending